Cargando…

Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics

Drugs against novel targets are needed to treat COVID-19 patients, especially as SARS-CoV-2 is capable of rapid mutation. Structure-based de novo drug design and repurposing of drugs and natural products is a rational approach to discovering potentially effective therapies. These in silico simulatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piplani, Sakshi, Singh, Puneet, Petrovsky, Nikolai, Winkler, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966092/ https://www.ncbi.nlm.nih.gov/pubmed/36835602 http://dx.doi.org/10.3390/ijms24044192

Ejemplares similares

In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase
por: Piplani, Sakshi, et al.
Publicado: (2022)

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M(pro)) as Potential COVID-19 Therapies
por: Piplani, Sakshi, et al.
Publicado: (2022)

Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies
por: Piplani, Sakshi, et al.
Publicado: (2021)

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein
por: Toelzer, Christine, et al.
Publicado: (2020)

Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV M(pro)
por: Niu, Chunying, et al.
Publicado: (2008)

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV
por: Awasthi, Mayanka, et al.
Publicado: (2020)

The free fatty acid–binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron
por: Toelzer, Christine, et al.
Publicado: (2022)

Cosolvent and Dynamic Effects in Binding Pocket Search by Docking Simulations
por: Szabó, P. Bernát, et al.
Publicado: (2021)

Role of Q675H Mutation in Improving SARS-CoV-2 Spike Interaction with the Furin Binding Pocket
por: Bertelli, Anna, et al.
Publicado: (2021)

Silibinin as potential tool against SARS‐Cov‐2: In silico spike receptor‐binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects
por: Speciale, Antonio, et al.
Publicado: (2021)

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
por: Li, Lei, et al.
Publicado: (2021)

Artemisia herba-alba sesquiterpenes: in silico inhibition in the ATP-binding pocket
por: Mohamed, Tarik A., et al.
Publicado: (2023)

An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
por: Tabynov, Kairat, et al.
Publicado: (2023)

Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis
por: Kemenesi, Gábor, et al.
Publicado: (2021)

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein
por: Ghoula, M., et al.
Publicado: (2023)

Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2
por: Yadav, Rohitash, et al.
Publicado: (2021)

In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2
por: Jafary, Farzaneh, et al.
Publicado: (2021)

Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study
por: Devi, Arpita, et al.
Publicado: (2021)

Binding of the SARS-CoV-2 spike protein to glycans
por: Hao, Wei, et al.
Publicado: (2021)

Heme binding to the SARS-CoV-2 spike glycoprotein
por: Freeman, Samuel L., et al.
Publicado: (2023)

Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis
por: Baindara, Piyush, et al.
Publicado: (2022)

Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein
por: Zuzic, Lorena, et al.
Publicado: (2022)

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective
por: Baldwin, Jeremy, et al.
Publicado: (2021)

Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters
por: Tabynov, Kairat, et al.
Publicado: (2023)

An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2020)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
por: Behera, Santosh Kumar, et al.
Publicado: (2021)

Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2
por: Biswas, Suvro, et al.
Publicado: (2022)

Identifying zoonotic origin of SARS-CoV-2 by modeling the binding affinity between Spike receptor-binding domain and host ACE2
por: Huang, Xiaoqiang, et al.
Publicado: (2020)

Molecular Dynamics of Rab7::REP1::GGTase-II Ternary Complex and Identification of Their Putative Drug Binding Sites
por: Sindhu, Meenakshi, et al.
Publicado: (2013)

In Silico Structural Homology Modelling and Docking for Assessment of Pandemic Potential of a Novel H7N9 Influenza Virus and Its Ability to Be Neutralized by Existing Anti-Hemagglutinin Antibodies
por: Rajapaksha, Harinda, et al.
Publicado: (2014)

Shape Theory Applied to Molecular Docking and Automatic Localization of Ligand Binding Pockets in Large Proteins
por: Ramírez-Velásquez, Iliana, et al.
Publicado: (2022)

Exploring polyamine interactions and binding pockets in SARS-CoV-2 ORF3a
por: Boonamnaj, Panisak, et al.
Publicado: (2023)

Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets
por: Verkhivker, Gennady, et al.
Publicado: (2022)

In Silico Docking, Molecular Dynamics and Binding Energy Insights into the Bolinaquinone-Clathrin Terminal Domain Binding Site
por: Abdel-Hamid, Mohammed K., et al.
Publicado: (2014)

A glycosaminoglycan microarray identifies the binding of SARS‐CoV‐2 spike protein to chondroitin sulfate E
por: Watanabe, Tomoko, et al.
Publicado: (2021)

In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
por: Bhowmik, Arijit, et al.
Publicado: (2021)

In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor
por: Zhang, Yuzhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gtnptcpf60d96606u99ivjpvam